Endogenous IL-12 synthesis is not required to prevent hyperexpression of type 2 cytokine and antibody responses

European Journal of Immunology

Volumn 30, Issue 2, 2000, Pages 347-355

  Rempel, Julia D ^a,b   Lewkowich, Ian P ^a   HayGlass, Kent T ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

^b Department of Neuropharmacology ^*  (United States)

Author keywords

Allergy; Cytokine; Th1 Th2 activation

Indexed keywords

CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; INTERLEUKIN 12; INTERLEUKIN 12 RECEPTOR; PROTEIN P40;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; CYTOKINE PRODUCTION; IMMUNIZATION; IMMUNOGLOBULIN BLOOD LEVEL; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRICHINELLA SPIRALIS;

ANIMALS; GENE EXPRESSION REGULATION; INTERFERON TYPE II; INTERLEUKIN-12; INTERLEUKIN-13; INTERLEUKIN-4; INTERLEUKIN-5; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; TH1 CELLS; TH2 CELLS;

EID: 0033974385     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/1521-4141(200002)30:2<347::AID-IMMU347>3.0.CO;2-H     Document Type: Article

References (51)

1. + T cell responses: the alternative approaches. Annu. Rev. Immunol. 1997. 15: 297-322.
2. Murphy, K. M., T lymphocyte differentiation in the periphery. Curr. Opin. Immunol. 1998. 10: 226-232.
3. O'Garra, A., Cytokines induce the development of functionally heterogeneous T helper cell subsets. Immunity 1998. 8: 275-283.
4. Huang, H., Hu Li, J., Chen, H., Ben-Sasson, S. Z. and Paul, W. E., IL-4 and IL-13 production in differentiated T helper type 2 cells is not IL-4 dependent. J. Immunol. 1997. 159: 3731-3738.
5. Yang, X. and HayGlass, K. T., Interferon gamma, but not IL-4, synthesis by antigen primed murine T cells is IL-2 dependent. Differential requirements in de novo and mature responses. J. Immunol. 1993. 150: 4354-4363.
6. Gately, M. K., Renzetti, L. M., Magram, J., Stern, A. S., Adorini, L, Gubler, U. and Presky, D. H., The IL-12/IL-12-Receptor System: role in normal and pathologic immune responses. Annu. Rev. Immunol. 1998. 16: 495-521.
7. Fitch, F. W., McKisic, M. D., Lancki, D. W. and Gajewski, T. F., Differential regulation of murine T lymphocyte subsets. Annu. Rev. Immunol. 1993. 11: 29-48.
8. + T cells to enhance priming for IFNγ production and diminished IL4 inhibition of such priming. Proc. Natl. Acad. Sci. USA 1993. 90: 10188-10192.
9. + T lymphocytes. J. Immunol. 1995. 155: 111-117.
10. + T cells through an effect on antigen-presenting cells. J. Immunol. 1995. 154: 2578-2587.
11. Piccotti, J. R., Li, K., Chan, S. Y., Ferrante, J., Magram, J., Eichwald, E. J. and Bishop, D. K., Alloantigen-reactive Th1 development in IL-12-deficient mice. J. Immunol. 1998. 160: 1132-1138.
12. HayGlass, K. T., Immunotherapy of Allergic Diseases. In Delves, P. J. and Roitt, I. (Eds.) Encyclopedia of Immunology. Academic Press, London 1999, pp 1353-1356.
13. Lester, M. R., Hofer, M. F., Gately, M., Trumble, A. and Leung, D. Y., Down-regulating effects of IL-4 and IL-10 on the IFNγ response in atopic dermatitis. J. Immunol. 1995. 154: 6174-6181.
14. Konig, B., Neuber, K. and Konig, W., Responsiveness of peripheral blood mononuclar cells from normal and atopic donors to microbial superantigens. Int. Arch. Allergy Immunol. 1995. 106: 124-133.
15. Naseer, T., Minshall, E. M., Leung, D. Y., Laberge, S., Ernst, P., Martin, R. J. and Hamid, Q., Expression of IL-12 and IL-13 mRNA in asthma and their modulation in response to steroid therapy. Am. J. Respir. Crit. Care Med. 1997. 155: 845-851.
16. van der Pouw-Kraan, T. C., Boeije, L. C., de-Groot, E. R., Sta-pel, S. O., Snijders, A., Kapsenberg, M. L., v.d. Zee, J. S. and Aarden, L. A., Reduced production of IL-12 and IL-12-dependent IFNγ release in patients with allergic asthma. J. Immunol. 1997. 158: 5560-5565.
17. HayGlass, K. T., Li, Y., Rempel, J. D., Wang, M. and Simons, F. E., Exogenous IL-12 and directed induction of human and murine Th1-associated responses: IL-12 and atopic immune responses. Int. Arch. Allergy Immunol. 1997. 113: 281-283.
18. Heinzel, F. P., Rerko, R. M., Ahmed, F. and Pearlman, E., Endogenous IL-12 is required for control of Th2 cytokine responses capable of exacerbating leishmaniasis in normally resistant mice. J. Immunol. 1995. 155: 730-739.
19. Hofstra, C. L., Van Ark, I., Hofman, G., Kool, M., Nijkamp, F. P. and Van Oosterhout, A. J., Prevention of Th2-like cell responses by coadministration of IL-12 and IL-18 is associated with inhibition of antigen-induced airway hyper-responsiveness, eosinophilia, and serum IgE levels. J. Immunol. 1998. 161: 5054-5060.
20. Magram, J., Connaughton, S. E., Warrier, R. R., Carvajal, D. M., Wu, C. Y., Ferrante, J., Steart, C., Sarmiento, U., Faherty, D. A. and Gately, M. K., IL-12-deficient mice are defective in IFNγ production and Type 1 cytokine responses. Immunity 1996. 4: 471-481.
21. Gazzinelli, R. T., Wysocka, M., Hayashi, S., Denkers, E. Y., Hieny, S., Caspar, P., Trinchieri, G. and Sher, A., Parasite-induced IL-12 stimulates early IFNγ synthesis and resistance dur© ing acute infection with Toxoplasma gondii. J. Immunol. 1994. 153: 2533-2543.
22. Heinzel, F. P., Hujer, A. M., Ahmed, F. N. and Rerko, R. M., In vivo production and function of IL-12 p40 homodimers. J. Immunol. 1997. 158: 4381-4388.
23. Neurath, M. F., Fuss, I., Kelsall, B. L., Stüber, E. and Strober, W., Antibodies to Interleukin 12 abrogate established experimental colitis in mice. J. Exp. Med. 1995. 182: 1281-1290.
24. + IFNγ producing cells. J. Immunol. 1997. 158: 643-648.
25. Rao, K. L., Varalakshmi, C., Ali, A. M. and Khar, A., Administration of anti-IL-12 antibody in vivo inhibits rejection of a rat histiocytoma and suppresses cytokine response in a tumour-bearing host. Immunology 1997. 92: 381-387.
26. Brewer, J. M., Tetley, L., Richmond, J., Liew, F. Y. and Alexander, J., Lipid vesicle size determines the Th1 or Th2 response to entrapped antigen. J. Immunol. 1998. 161: 4000-4007.
27. Wu, C., Ferrante, J., Gately, M. K. and Magram, J., Characterization of IL-12 receptor betal chain (IL-12Rbeta1)-deficient mice: IL-12Rbeta1 is an essential component of the functional mouse IL-12 receptor. J. Immunol. 1997. 159: 1658-1665.
28. Altare, F., Durandy, A., Lammas, D., Emile, J. F., Lamhamedi, S., LeDeist, F., Drysdale, P., Jouanguy, E., Doffinger, R., Bernaudin, F., Jeppsson, O., Gollob, J., Meinl, E., Segal, A. W., Fischer, A., Kumararatne, D. and Casanova, J. L., Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency. Science 1998. 280: 1432-1435.
29. de Jong, R., Altare, F., Haagen, I. A., Elferink, D. G., Boer, T., v. Breda-Vriesman, P. J., Kabel, P. J., Draaisma, J. M., v. Dissel, J. T., Kroon, F. P., Casanova, J. L. and Ottenhoff, T. H., Severe mycobacterial and Salmonella infections in interleukin-12 receptor-deficient patients. Science 1998. 280: 1435-1438.
30. Anguita, J., Persing, D. H., Rincón, M., Barthold, S. W. and Fikrig, E., Effect of anti-interleukin 12 treatment on murine lyme borreliosis. J. Clin. Invest. 1996. 97: 1028-1034.
31. Mattner, F., Magram, J., Ferrante, J., Launois, P., Di Padova, K., Gehin, R., Gately, M. K., Louise, J. A. and Alber, G., Genetically resistant mice lacking interleukin-12 are susceptible to infection with Leishmania major and mount a polarized Th2 cell response. Eur. J. Immunol. 1996. 26: 1553-1559.
32. Cooper, A. M., Magram, J., Ferrante, J. and Orme, I. M., Interleukin-12 (IL-12) is crucial to the development of protective immunity in mice intravenously infected with Mycobacterium tuberculosis. J. Exp. Med. 1997. 186: 39-45.
33. Yoshimoto, T., Wang, C. R., Yoneto, T., Waki, S., Sunaga, S., Komagata, Y., Mitsuyama, M., Miqazaki, J. and Nariuchi, H., Reduced T helper 1 responses in IL-12 p40 transgenic mice. J. Immunol. 1998. 160: 588-594.
34. Schijns, V. E. C. J., Haagmans, B. L., Wierda, C. M., Kruithof, B., Heijnen, I. A., Alber, G. and Horzinek, M. C., Mice lacking IL-12 develop polarized Th1 cells during viral infection. J. Immunol. 1998. 160: 3958-3964.
35. Wakeham, J., Wang, J., Magram, J., Croitoru, K., Harkness, R., Dunn, P., Zganiacz, A. and Xing, Z., Lack of both types 1 and 2 cytokines, tissue inflammatory responses, and immune protection during pulmonary infection by Mycobacterium bovis bacille Calmette-Guerin in IL-12-deficient mice. J. Immunol. 1998. 160: 6101-6111.
36. Yang, X. and HayGlass, K. T., Allergen dependent induction of interleukin-4 synthesis in vivo. Immunology 1993. 78: 74-79.
37. Kuhn, R., Rajewsky, K. and Muller, W., Generation and analysis of interleukin-4 deficient mice. Science 1991. 254: 707-710.
38. Noben-Trauth, N., Kropf, P. and Müller, I., Susceptibility to Leishmania major infection in interleukin-4-deficient mice. Science 1996. 271: 987-990.
39. Kropf, P., Etges, R., Schopf, L., Chung, C., Sypek, J. and Müller, I., Characterization of T cell-mediated responses in non-healing and healing Leishmania major infections in the absence of endogenous IL-4. J. Immunol. 1997. 159: 3434-3443.
40. Schuler, T., Qin, Z., Ibe, S., Noben-Trauth, N. and Blankenstein, T., T helper cell type1-associated and cytotoxic T lymphocyte-mediated tumor immunity is impaired in interleukin 4-deficient mice. J. Exp. Med. 1999. 189: 803-810.
41. Szabo, S. J., Jacobson, N. G., Dighe, A. S., Gubler, U. and Murphy, K. M., Developmental commitment to the Th2 lineage by extinction of IL-12 signaling, immunity 1995. 2: 665-675.
42. Chang, J. T., Shevach, E. M. and Segal, B. M., Regulation of interleukin (IL)-12 receptor β2 subunit expression by endogenous IL-12: A critical step in the differentiation of pathogenic autoreactive T cells. J. Exp. Med. 1999. 189: 969-978.
43. Rempel, J. D., Wang, M. D. and HayGlass, K. T., In vivo IL-12 administration induces profound but transient commitment to T helper type 1-associated patterns of cytokine and antibody production. J. Immunol. 1997. 159: 1490-1496.
44. Keane-Myers, A., Wysocka, M., Trinchieri, G. and Wills-Karp, M., Resistance to antigen-induced airway hyperresponsiveness requires endogenous production of IL-12. J. Immunol. 1998. 161: 919-926.
45. Wu, C. Y., Demeure, C. E., Gately, M., Podlaski, F., Yssel, H., Kiniwa, M. and Delespesse, G., In vitro maturation of human neonatal CD4 T lymphocytes. I. Induction of IL-4-producing cells after long-term culture in the presence of IL-4 plus either IL-2 or IL-12. J. Immunol. 1994. 152: 1141-1153.
46. Engwerda, C. R., Murphy, M. L., Cotterell, S. E., Smelt, S. C. and Kaye, P. M., Neutralization of IL-12 demonstrates the existence of discrete organ-specific phases in the control of Leishmania donovani. Eur. J. Immunol. 1998. 28: 669-680.
47. Takeda, K., Tsutsui, H., Yoshimoto, T., Adachi, O., Yoshida, N., Kishimoto, T., Okamura, H., Nakanishi, K. and Akira, S., Defective NK cell activity and Th1 response in IL-18-deficient mice. Immunity 1998. 8: 383-390.
48. + T cells resulting in a state of unresponsivenesses to IL-12. J. Immunol. 1998. 161: 6156-6163.
49. deVos, T. and Dick, T. A., The mucosal and systemic response to phosphorylcholine in mice infected with Trichinella spiralis. Exp. Parasitol. 1993. 76: 401-411.
50. HayGlass, K. T. and Stefura, W. P., Anti-IFNγ treatment blocks the ability of glutaraldehyde polymerized allergens to inhibit specific IgE responses. J. Exp. Med. 1991. 173: 279-285.
51. Yang, X., Gieni, R., Mosmann, T. R. and HayGlass, K. T., Chemically modified antigen preferentially elicits induction of Th1-like cytokine synthesis patterns in vivo. J. Exp. Med. 1993. 178: 349-453.